Mounting evidence supports current theories linking lipoprotein oxidation to atherosclerosis. We sought the cellular biochemical mechanism by which oxidized LDL inflicts cell injury. Inhibitors of candidate pathways of cell death were used to treat human fibroblast target cells exposed to oxidized LDL. Ebselen, which degrades lipid hydroperoxides, inhibited oxidized LDL toxicity, consistent with our recent report that 7f8-hydroperoxycholesterol (7fi-OOH chol) is the major cytotoxin of oxidized LDL. Intracellular chelation of metal ions inhibited, while preloading cells with iron enhanced, toxicity. Inhibition of oxidized LDL and 7/B-OOH chol toxicity by 2-keto-4-thiolmethyl butyric acid, a putative alkoxyl radical scavenger and by vitamin E, probucol and diphenylphenylenediamine, putative scavengers of peroxyl radicals was consistent with the involvement of these radicals in the lethal sequence. Cell death was thus postulated to occur due to lipid peroxidation via a sequence involving lipid hydroperoxide-induced, iron-mediated formation of alkoxyl, lipid, and peroxyl radicals. Pathways involving other reactive oxygen species, new protein synthesis, or altered cholesterol metabolism were considered less likely, since putative inhibitors failed to lessen toxicity. Understanding the mechanism of cell injury by oxidized LDL and its toxic moiety, 7J3-OOH chol, may indicate specific interventions in the cell injury believed to accompany vascular lesion development. (J. Clin. Invest. 1995Invest. . 96:1866Invest. -1873
Introduction
There is growing circumstantial evidence that oxidation of LDL is linked to the risk of atherosclerosis (1, 2) . In vitro, oxidized LDL markedly alters the function of vascular cells, monocytes and macrophages (3) . In addition, oxidized LDL has been found to be present in atherosclerotic lesions (4) .
Oxidized LDL has also been shown to be toxic to vascular cells in vitro (5) (6) (7) (8) and it has been hypothesized that this toxicity may be a factor in lesion development (9) (10) (11) . We and others have studied aspects of oxidized LDL induced cytotoxic-ity in certain cell systems using various preparations of oxidized LDL. Oxidized LDL toxicity does not appear to be cell specific (5, 6, 12) , nor does it require LDL receptors (13, 14) . An association between fibroblasts passing through DNA synthesis phase (S-phase) and vulnerability to oxidized LDL induced cell death has been established ( 15 ) . In a recent study we identified the most potent toxic fraction of oxidized LDL as 7/3-hydroperoxycholesterol (7, and showed the presence of this oxysterol in human carotid atherosclerotic lesions (16) . The toxicity of oxidized LDL to vascular cells could theoretically play a role in atherosclerotic lesion development. The mechanism by which oxidized LDL is cytotoxic remains unknown.
A better understanding of the mechanism involved in oxidized LDL induced cytotoxicity will make it possible to study whether oxidized LDL injures cells in vivo and to tailor a clinically relevant therapeutic approach against oxidized LDL induced cell injury. Hence, we employed a pharmacological approach using various antioxidants, radical scavengers, chelators, and enzyme inhibitors to discern the intracellular intermediates involved in the mechanism of oxidized LDL-induced cytotoxicity.
Methods
Materials. NN'-diphenyl-1,4-phenylene-diamine (DPPD),' DMSO and 1,10-phenanthroline were purchased from Aldrich Chemical Co. (Milwaukee, WI). Reduced (-17 Ci/mg) were obtained from ICN (Irvine, CA). EDTA, acetonitrile, isopropanol, hexane, ethanol, acetone, methanol, and chloroform were purchased from Fisher Scientific. Dulbecco's modified essential medium (DME) was purchased from Whittaker Bioproducts (Walkersville, MD). A mixture of equal parts of DME and Ham's F12 (DME/ F12) was purchased from Irvine Scientific (Irvine, CA). Probucol was a generous gift from Marion Merrell Dow Pharmaceuticals (Cincinnati, OH). EGF was obtained from Clonetics (San Diego, CA). All other reagents came from Sigma Chemical Co. (St. Louis, MO) .
Lipoproteins. LDL (1.019 grams/ml 5 solvent density -1.063 grams/ml) was prepared by sequential centrifugation from pooled, citrated human plasma according to a modification (15) (7) . Cells from a single donor were used in any particular experiment. Cells from numerous donors were used throughout the study. Cells were maintained in DME/F12 supplemented with 5-10% FBS, (Whittaker Bioproducts).
Cell synchronization and pretreatment. Cells were synchronized (except where noted) using a double thymidine block as previously described ( 15, 22) . Subconfluent cultures of human foreskin fibroblasts (passage 2 through 7) were plated on 24-or 48-well tissue culture clusters (Costar, Cambridge, MA) in DME/F12 supplemented with 10% FBS and 2 mM thymidine. After 16 to 24 h, the cells were rinsed twice with media to remove the excess thymidine and fresh media with 10% FBS was added. After 9 to 11 h, this media was removed and the cells rinsed twice with plain media. During the second 2 mM thymidine block, various pretreatment media were added to the cells (DME, 4 mg protein/ml LPDS, 100 ng/ml EGF, 2 mM thymidine, 0.2 /Ci/ml ['4C ] adenine, plus pretreatment compounds or controls, as indicated). In experiments in which [3H]thymidine incorporation into DNA was to be measured, the 2 mM thymidine was replaced with hydroxyurea (2-4 mM) for the second block. Appropriate solvent controls were used in all cases in which pretreatment compounds were added in solvents other than DME. After 12 h, the cells were washed twice with media and media containing lipoproteins was added (DME, 4 mg protein/ml LPDS, 100 ng/ml EGF, plus lipoproteins). 20 h later the cells were assayed for cytotoxicity and cell survival.
Cell survival and cytotoxicity. For cell enumeration, cells were detached by trypsinization, diluted with isotonic saline, and counted using a Coulter Counter (Coulter Electronics Model ZM) as previously described (6, 7).
Release of "4C-labeled compounds into the media by cells preloaded with [ '4C] adenine was used as a measure of relative cell injury and/or death, as previously described (23) . Toxicity in the wells was then calculated as the percent specific release of '4C-labeled compounds using Triton X-100 released '4C as 100% and 14C released from control wells as 0%.
HPLC isolation of 7/3-OOH chol. Aliquots of oxidized LDL containing up to 8 mg total cholesterol were frozen (-70°C) and lyophilized. Lipids were extracted with acetone three times and stored dry (-70°C) under argon. The extracted lipids were resuspended in 1:1 (vol/vol) acetonitrile:isopropanol and separated by reverse phase preparative HPLC using a Waters 19 mm x 15 cm /tBondapak C18 column and a water/acetonitrile/isopropanol gradient mobile phase as described previously (16) . This was followed by further separation of the 7,6-OGH chol-containing fraction using a CN column (Waters 3.9 mm x 300 pm ,uBondapak) and 3% isopropanol in hexane as isocratic solvent. We have previously shown this procedure to yield highly purified 7,l-OOH chol (16) .
[3H]Thymidine incorporation into DNA. Cells were incubated with
[3H]thymidine (1.0 yCi/ml) in culture media during selected experiments for various periods of time as indicated. At the end of the exposure period, the cell layers were rinsed twice with ice cold 10% trichloroacetic acid (TCA) and solubilized in 0.25 N NaOH at room temperature. Cell associated radioactivity was determined by liquid scintillation counting ( 15) .
Jodination and degradation oflipoproteins. Lipoproteins were iodinated with Na'25I ( 17 Ci/mg in 0.1 N NaOH) using the iodine monochloride injection method of McFarlane (24) . Thin layer chromatographic separation and quantification of iodinated lipoprotein metabolic breakdown products (mono-and diiodotyrosine and iodide) was performed using the method of Chisolm et al. (25) .
[ 
Results
Lysosomal enzyme inhibitors. We first asked whether lysosomal degradation of oxidized LDL is required for oxidized LDL induced cell death pathway. Oxidized LDL could hypothetically be transformed by lysosomal enzymes to a toxic molecule and subsequently cause cell death. We employed nontoxic concentrations of the lysosomal enzyme inhibitors chloroquine (25 MM) and ammonium chloride (10 mM). At these concentrations the agents inhibited the lysosomal protein degradation by > 90% using native LDL as an indicator; however no protection against oxidized LDL induced cytotoxicity was found.
Interference with cellular cholesterol metabolism. Particular oxysterols have been shown to interfere with cellular cholesterol metabolism and for some, this interference leads to cell death that can be inhibited by supplying the cell with unoxidized free cholesterol (28). Since cell injury by oxidized LDL had been linked to oxysterols ( 16, 29) , we determined whether supplying exogenous cholesterol to cells would inhibit oxidized LDL toxicity. Marked increases in total cell cholesterol, achieved by pretreatment with cholesterol-albumin coacervates, did not inhibit toxicity.
Ebselen: a seleno-peroxidase mimetic. It has been reported that the synthetic seleno-organic compound Ebselen has lipid hydroperoxide-reducing activity (30) and in light of our finding that 7,3-OOH chol is the major oxidized LDL-borne cytotoxin (16), we examined whether Ebselen protects against oxidized LDL induced cell death in human fibroblast cells. (37) , Tiron, a well-characterized chelator of intracellular transition metal ions (38) , was also tested. Fig. 2 A reveals that pretreatment with Tiron protected fibroblasts in a concentration dependent fashion. Pretreatment with Tiron (10 mM) also protected cells against 7,B-OOH chol induced injury as seen in Fig.  2 B. 1,10-Phenanthroline, another metal chelator shown to be active intracellularly (39) , was tested and also showed significant protection against oxidized LDL induced cytotoxicity at a 100 ,uM concentration, but only when employed as a treatment concurrent with oxidized LDL exposure as seen in Fig. 3 A. 7POOH cholesterol Figure 2 . The effect of Tiron on oxidized LDL and 713-OOH chol induced cytotoxicity. Fibroblasts were synchronized using a double thymidine block (see Methods). During the second thymidine block, various concentrations of Tiron dissolved in media were added to the cells. The cells were released from the second thymidine block and either oxidized LDL (250 pg cholesterol/ml) (A), or 7/3-OOH chol (1.46 ,pgl ml) in acetone/ethanol (0.5% final concentration) or solvent alone, was added (B). Cytotoxicity was assayed by measuring specific 14C release into the media as described (see Methods).
(Pretreatment with higher concentrations, e.g., 150 ,uM, was toxic to cells). 1,0 O-Phenanthroline (75 ,ttM) likewise protected fibroblasts from 7/3-OOH chol when employed as a concurrent treatment (see Fig. 3 B) .
Using an alternate approach, we attempted to clarify further the role of intracellular iron in oxidized LDL induced cytotoxicity by preloading fibroblasts with iron and then exposing them to sublethal concentrations of oxidized LDL or 7/3-OOH chol. Specifically, we pretreated the fibroblasts with 10 ,uM ferric ammonium citrate and 2 mM 8-hydroxyquinoline as described (40) . The potential roles of superoxide anion, singlet oxygen, hydrogen peroxide, and hydroxyl radical. We used several free radical scavengers known to scavenge superoxide anion intracellularly in an attempt to clarify whether superoxide participates in oxidized LDL induced cell death. Superoxide dismutase conjugated with polyethylene glycol (SOD-PEG, 3500 U/ml), and Cu-3,5-diisopropylsalicylic acid (25 to 100 MM) did not offer any protection against cell death at concentrations demonstrated by others to be effective scavengers in various cell systems (41, 42) . Moreover, the xanthine oxidase inhibitor, allopurinol (0.1-0.3 mg/ml), showed no protection against oxidized LDL induced cytotoxicity (data not shown).
An attempt was also made to determine whether hydroxyl radical ( OH), a product of the Haber-Weiss reaction, was involved in the death mechanism. The -OH scavengers, mannitol (20-40 mM), DMSO (I to 2% by volume), and tryptophan (1.0-5 mM), offered no protection against oxidized LDL induced cytotoxicity (data not shown). Histidine (1-40 mM), reported to scavenge both hydroxyl radical and singlet oxygen (43) , was likewise ineffective as an inhibitor.
A possible role for hydrogen peroxide was also examined. Several experiments using catalase (0.03-1 MM) were performed in which no protection was observed. (Catalase at concentrations of above 0.3 MM or above inhibited fibroblast proliferation; data not shown). In an alternate approach, poly (ADPribose) polymerase inhibitors were utilized to examine whether an increase in poly (ADP-ribose) polymerase activity secondary to DNA damage was involved in oxidized LDL induced cytotoxicity, as has been documented for H202-induced cell death (44, 45 (47, 48) was used to determine whether alkoxyl radicals could be intermediate in the sequence of oxidized LDL induced cytotoxicity. As shown in Fig. 5, 40 mM KTBA pretreatment protected fibroblasts against oxidized LDL. In the same experiment, 10 and 20 mM pretreatments of KTBA for 16 h also protected cells. These results are consistent with alkoxyl radical participation in the mechanism by which oxidized LDL causes cell death.
Involvement of lipid and lipid peroxyl radicals (Lo and LOO ). Iron-mediated lipid hydroperoxide reduction and alkoxyl radical formation can lead to the production of peroxyl radical (34) . Since peroxyl radicals are believed to play a significant role in the propagation of lipid peroxidation (49), we tested potential protection by vitamin E and probucol, both known to scavenge peroxyl radicals (50, 51) , and both were protective against cellular injury by oxidized LDL (52) , as demonstrated in Fig. 6 and 7 . Vitamin E and probucol have the capacity to scavenge alkoxyl and lipid radicals in addition to peroxyl radicals (49, 52) . Since DPPD has been reported to scavenge lipid and peroxyl radicals (53), we also used this antioxidant to test inhibition. The results in Fig. 8, A synchronized cells exposed to toxins as they were released into S-phase, the phase of the cell cycle during which we have previously shown markedly enhanced susceptibility to oxidized LDL induced injury ( 15 to injure cells. Specifically, we removed the oxidized LDL containing supernatant that had been incubated with pretreated (vitamin E) and unpretreated fibroblasts and placed it on fresh proliferating fibroblasts to compare the cytotoxicities of the two. The oxidized LDL incubated with the pretreated cells was not less toxic (data not shown).
In another experiment, we prepared oxidized LDL and used a concentration chosen for which we could verify that subsequent oxidation did not further enhance its cytotoxicity. This oxidized LDL was exposed to fibroblasts pretreated with the inhibitors, probucol and DPPD. These inhibitors, employed as pretreatments, protected against this oxidized LDL as well (data not shown). The results indicated that the inhibitors tested were protecting against oxidized LDL induced cytotoxicity by a mechanism other than blocking the further oxidation of LDL. This is consistent with the idea that a pretreatment that successfully inhibited toxicity did so by altering cellular events.
We also considered whether the inhibitors tested afforded protection secondarily by blocking the cellular uptake, processing, or metabolism of oxidized LDL rather than interfering directly with a cell death mechanism. To examine this possibility, we measured radiolabeled oxidized LDL degradation rates under the influence of selected inhibitors. The inhibitors Tiron and probucol, used at concentrations at which they were successful inhibitors of toxicity, did not decrease radiolabeled oxidized LDL degradation (data not shown).
Discussion
The cellular mechanism involved in oxidized-LDL induced cell death. Ebselen has been reported to reduce hydroperoxides to their corresponding alcohols (54) . There have been suggestions by some that Ebselen can also scavenge free radicals (54) ; however, others show it is not a potent radical scavenger, and its antioxidant capacity does not seem to be related to a free 1870 Coffey et al. (44) to initiation of lipid peroxidation through the formation of alkoxyl radicals (see Fig. 9 ) (56). Many chelators are not exclusively metal scavengers. Under certain circumstances, Tiron may scavenge -OH, superoxide anion, alkyl, and alkoxyl radicals (38) and Desferal may also quench peroxyl radicals (37) . We therefore used multiple intracellularly active metal chelators at various concentrations in an attempt to demonstrate more confidently the transition metal involvement in oxidized LDL induced cytotoxicity. Our data show the metal chelators Tiron, Desferal and 1,10-phenanthroline protected cells while EDTA and DTPA, which cannot readily enter cells (47) , showed no protection. Furthermore, preloading cells with iron rendered toxic even sublethal concentrations of oxidized LDL. The inhibition we observed is not secondary to the inhibition of cell cycle progression by limiting cellular iron availability as has been reported to occur (57) , since Desferal and Tiron inhibited 7fi-OGH chol toxicity to quiescent cells. Our findings, taken together, strongly suggest transition metals, namely cellular iron, play a role in oxidized LDL induced cell death.
To understand how iron mediates oxidized LDL cytotoxicity, several metal iron-mediated pathways known to induce cell death were considered. We observed no protection by poly -(ADP-ribose) polymerase inhibition, suggesting that DNA strand breakage, as described by Shraufstatter et al. (44) to explain lethal H202 effects on cells, is unlikely. Similarly, our experiments using a hydrogen peroxide scavenger, a singlet oxygen scavenger, superoxide scavengers, and hydroxyl radical scavengers, many of which scavenge reactants or products of the iron-mediated Fenton and Haber-Weiss reactions, showed no protection. These results suggested that another iron-dependent pathway was involved.
Iron has also been associated with the propagation of lipid peroxidation (36, 38, 56) . Farber and others suggested a relationship between lipid peroxidation and cell death which they observed when hepatocytes were treated with tert-butyl hydroperoxide (34) . We used the antioxidants vitamin E and probucol and both inhibited oxidized LDL toxicity. It has been reported that reactivity with organic peroxyl radicals (LOO * ) accounts for most of the antioxidant activity of vitamin E (49, 50). Pryor et al. showed that probucol scavenges peroxyl radicals, and they suggested the antioxidant activity of probucol is at least comparable to vitamin E (51 ). A conclusive statement on the direct relationship between lipid peroxidation and fibroblast cell death cannot be made solely from the protective effects of vitamin E and probucol, since other radicals (e.g., alkoxyl radical) can also be scavenged by these agents (58). Our results using KTBA, a putative alkoxyl radical scavenger, are consistent with the idea that alkoxyl radicals play a role in oxidized LDL induced cell death. However since alkoxyl radicals are able to induce oxidative cell damage independent of lipid peroxidation (34) Fig. 9 . We believe our results to be consistent with a role for iron reacting with lipid hydroperoxides of oxidized LDL such as 7/3-hydroperoxycholesterol to form in succession, alkoxyl radicals, Cellular Mechanism of Oxidized LDL-induced Cytotoxicity lipid radicals and peroxyl radicals from cellular lipids. Cell death follows from the amplified peroxidation of cellular lipids shown in Fig. 9 . We can only speculate on the origin of the affected cellular lipids. They may come from any cellular lipid pool, including the plasma membrane. Inherent in a pharmacological study such as this one is the possible occurrence of false positive results (apparent inhibition), due to additional actions of a putative inhibitor, or false negative results, due to its unforeseen inactivation. We have taken several precautions to minimize false interpretations (see Results), including testing selective inhibitors against interference with cell cycle progression, low cellular uptake, poor intracellular distribution, nonoptimal concentrations of the compounds tested, toxicity of the putative inhibitor, or interference with further LDL oxidation during incubation. We shortened the time of exposure of oxidized LDL to cells, we used a metal ion poor cell culture medium to reduce further LDL oxidation, and we used cell pretreatments with putative inhibitors where possible. The compounds and the concentrations we used were selected from published reports which demonstrated the effectiveness of the tested compound in other cell systems and we used multiple inhibitors where available.
Other researchers have studied the inhibition of oxidized LDL-induced cytotoxicity in a variety of cell systems using a number of different types of preparations of oxidized LDL ( 11 ). Kuzuya et al. showed that metal ion chelators, vitamin E, and probucol inhibited the toxicity of a particularly toxic variant of oxidized LDL, one in which ferrous or cupric ions remained bound to the oxidized LDL after oxidation (52, 59) . The similar action of the few inhibitors they used suggests that the mechanism of cell death of their preparation may be analogous to ours and that their metal ion containing preparation of oxidized LDL may act as a carrier of additional metal ion into the cell, serving the same purpose as the cell loading of iron we (Fig. 4) and others achieved using 8-hydroxyquinoline (58) .
Negre-Salvayre and coworkers have explored certain aspects of oxidized LDL induced cell death employing LDL oxidized by UV irradiation, which has properties distinct from LDL oxidized by metals, and using a transformed lymphoblast cell line as target cells ( 12, 60) . They studied the effectiveness of probucol, vitamin E, and the flavonoids catechin and quercetin, against cytotoxicity induced by UV irradiated LDL (61, 62) . Their data suggested the flavonoids and vitamin E inhibited toxicity; however, in contradistinction to our results and those of others (52, 58) , probucol was ineffective (61) . This discrepancy may relate to the differences in LDL oxidized by UV irradiation versus metals (see above) or differences in susceptibility of various target cells. Thomas et al. (58) examined the cytotoxicity of another preparation of oxidized LDL, using photooxidation rather than metal-mediated oxidation. They also used various antioxidants as inhibitors and found that Ebselen, Desferal, butylated hydroxytoluene, and probucol protected bovine aortic endothelial cells against oxidized LDL induced cytotoxicity. Their results were generally consistent with ours but were inconclusive as to whether lipid peroxidation was indeed the cause of cell death or whether cell death involved superoxide ion or was due to another alkoxyl radical-mediated pathway, such as DNA or protein damage (34) . Our data using the intracellular superoxide scavengers, Cu-3,5-diisopropylsalicylic acid and SOD-PEG, suggest a lack of superoxide involvement.
While it is known that oxidized LDL and 7,6-OOH chol are found in arterial lesions in vivo, it is unknown whether they play a role in atherosclerosis. LDL at concentrations similar to plasma concentration levels has been found in atherosclerotic lesions (63, 64), but the degree to which it is oxidized is unknown. This raises the question of whether these concentrations of oxidized LDL can lead to injury of the endothelium in early atherosclerosis (65) and/or necrosis in late stage plaque formation. The mechanism of oxidized LDL induced cell death we have presented will hopefully lead to a better understanding of the role of oxidized LDL in atherosclerosis, since identification of the radical intermediates suggests various sites of intervention and also suggests intermediates that could be active in the numerous biological functions attributed to oxidized LDL at sublethal concentrations.
